Besides podocytes, berberine can also upregulate the expression of CPT1 and PPARα in renal TECs, further improving mitochondrial FAO and reducing lipid accumulation in DKD mice (Rong et al., 2021). This evidence concerns the gene CPT2 and diabetic kidney disease.